Crossref
4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY
Surgery for Obesity and Related Diseases · 2026-04 · 22 (4) · S65-S66
DOI: 10.1016/j.soard.2026.02.217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery for Obesity and Related Diseases, 2026-04.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). 4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY. Surgery for Obesity and Related Diseases, 22(4), S65-S66. https://doi.org/10.1016/j.soard.2026.02.217
Vancouver
4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY. Surgery for Obesity and Related Diseases. 2026;22(4):S65-S66. doi:10.1016/j.soard.2026.02.217
BibTeX
@article{euvimed2026,
title = {4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY},
journal = {Surgery for Obesity and Related Diseases},
year = {2026},
volume = {22},
number = {4},
pages = {S65--S66},
doi = {10.1016/j.soard.2026.02.217}
}
EUVIMED